{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:48:11Z","timestamp":1761709691964,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ijcard.2019.11.099","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:35:29Z","timestamp":1574076929000},"page":"163-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Ventricular repolarization dynamics in arsenic trioxide treatment of acute promyelocytic leukemia"],"prefix":"10.1016","volume":"306","author":[{"given":"Yinan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimei","family":"Que","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengju","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.11.099_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/17474086.2019.1562332","article-title":"Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia","volume":"12","author":"Breccia","year":"2019","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12185-014-1603-1","article-title":"Progress in the treatment of acute promyelocytic leukemia: optimization and obstruction","volume":"100","author":"Li","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0015","first-page":"178","article-title":"Acute promyelocytic leukemia: a summary","volume":"9","author":"Ryan","year":"2018","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0020","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/cncr.31327","article-title":"Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: a 15-year prospective study","volume":"124","author":"Gill","year":"2018","journal-title":"Cancer."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","article-title":"Drug-induced inhibition and trafficking disruption of ion channels: pathogenesis of QT abnormalities and drug-induced fatal arrhythmias","volume":"12","author":"Cubeddu","year":"2016","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0030","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.etap.2015.08.030","article-title":"Arsenic cardiotoxicity: an overview","volume":"40","author":"Alamolhodaei","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12012-018-09504-7","article-title":"An overview on arsenic trioxide-induced cardiotoxicity","volume":"19","author":"Vineetha","year":"2019","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0040","first-page":"79","article-title":"Incident adverse events following therapy for acute promyelocytic leukemia","volume":"9","author":"Kim","year":"2018","journal-title":"Leuk. Res. Rep."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0045","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1200\/JCO.2013.51.2913","article-title":"Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide","volume":"32","author":"Roboz","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/ijn.IJN_15_18","article-title":"Effect of hemodialysis on corrected QT interval and QTc dispersion","volume":"28","author":"Sohal","year":"2018","journal-title":"Indian J. Nephrol."},{"issue":"2","key":"10.1016\/j.ijcard.2019.11.099_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12376","article-title":"Comprehensive electrocardiographic analysis of lead exposed workers: an arrhythmic risk assessment study","volume":"22","author":"Karakulak","year":"2017","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1091581818813601","article-title":"A proof-of-concept evaluation of JTPc and Tp-Tec as proarrhythmia biomarkers in preclinical species: a retrospective analysis by an HESI-sponsored consortium","volume":"38","author":"Boulay","year":"2019","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0065","first-page":"397","article-title":"Evaluation of ventricular repolarization features with novel electrocardiographic parameters (Tp-e, Tp-e\/QT) in patients with psoriasis","volume":"18","author":"Arisoy","year":"2017","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164309","article-title":"Time-to-onset analysis of drug-induced long QT syndrome based on a spontaneous reporting system for adverse drug events","volume":"11","author":"Sasaoka","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2019.11.099_bb0075","first-page":"20","article-title":"Regional QT interval dispersion as an early predictor of reperfusion in patients with acute myocardial infarction after fibrinolytic therapy","volume":"112","author":"Dotta","year":"2019","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188555","article-title":"Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients","volume":"12","author":"Kimura","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2019.11.099_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1568009617666161121141607","article-title":"Cardiotoxicity in hematologic malignancies","volume":"17","author":"Stellitano","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ijcard.2019.11.099_bb0090","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1200\/JCO.2003.10.009","article-title":"Effect of arsenic trioxide on QT interval in patients with advanced malignancies","volume":"21","author":"Barbey","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/leu.2011.245","article-title":"Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia","volume":"26","author":"Lengfelder","year":"2012","journal-title":"Leukemia."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0100","first-page":"4061","article-title":"Early mortality in acute promyelocytic leukemia: potential predictors","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00210-014-1019-8","article-title":"The rescuable function and mechanism of resveratrol on As(2)O(3)-induced hERG K(+) channel deficiency","volume":"387","author":"Zhao","year":"2014","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ijcard.2019.11.099_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005482","article-title":"Synergistic effect of dofetilide and mexiletine on prevention of atrial fibrillation","volume":"6","author":"Liu","year":"2017","journal-title":"J. Am. Heart Assoc."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319341026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319341026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:46:56Z","timestamp":1759092416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319341026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":22,"alternative-id":["S0167527319341026"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.099","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ventricular repolarization dynamics in arsenic trioxide treatment of acute promyelocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}